Bortezomib-Dexamethasone, Rituximab, and Cyclophosphamide as First-Line Treatment for Waldenström's Macroglobulinemia: A Prospectively Randomized Trial of the European Consortium for Waldenström's Macroglobulinemia

1. Buske, C.
2. Dimopoulos, M.A.
3. Grunenberg, A.
4. Kastritis, E.
5. Tomowiak, C.
6. Mahé, B.
7. Troussard, X.
8. Hajek, R.
9. Viardot, A.
10. Tournilhac, O.
11. Aurran, T.
12. Lepretre, S.
13. Zerazhi, H.
14. Hivert, B.
15. Leblond, V.
16. de Guibert, S.
17. Brandefors, L.
18. Garcia-Sanz, R.
19. Gomes da Silva, M.
20. Kimby, E.
21. Schmelzle, B.
22. Kaszynski, D.
23. Dreyhaupt, J.
24. Muche, R.
25. Morel, P.